Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Spinal muscular atrophy (SMA) is a rare and devastating disease. New disease-modifying treatments have recently been approved and early treatment has been related to a better outcome. In this context, several newborn screening (NBS) programs have been implemented. The aim of the study was to obtain a global overview on the current situation and perspectives on SMA NBS. We conducted a survey and contacted experts from 152 countries, from which we gathered 87 responses. We identified 9 SMA NBS programs that have so far detected 288 newborns with SMA out of 3,674,277 newborns screened. Funding, screening methods, organisation, and consent process were variable between SMA NBS programs. Many respondents pointed the lack of cost/benefit data as a major obstacle to SMA NBS implementation. In the next four years, our data suggest a 24% coverage of newborns from countries where a disease-modifying drug is available and 8,5% coverage in countries with no diseases-modifying drugs. The annual proportion of newborns to be screened in the coming years is expected to increase steadily. The experts expressed a strong need for the implementation of SMA NBS as means to improve care for patients with SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., Chiriboga, C. A., Saito, K., Servais, L., Tizzano, E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702752 · Cited by 2,337
Self-citationVerhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmüller, H. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0671-8 · Cited by 739
Cited by
Mercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T., & Finkel, R. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00380-8 · Cited by 430
Strauss, K. A., Farrar, M. A., Muntoni, F., Saito, K., Mendell, J. R., Servais, L., McMillan, H. J., Finkel, R. S., Swoboda, K. J., Kwon, J. M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01866-4 · Cited by 316
Self-citation
Metadata
- Authors
- Dangouloff, T., Vrščaj, E., Servais, L., Osredkar, D., Adoukonou, T., Aryani, O., Barisic, N., Bashiri, F., Bastaki, L., Benitto, A., Omran, T. B., Bernert, G., Bertini, E., Borde, P., Born, P., Boustani, R.-M., Butoianu, N., Castiglioni, C., Catibusic, F., Chan, S., Chien, Y. H., Christodoulou, K., Dejsuphong, D., Farrar, M., Filip, D., Goemans, N., Guinhouya, K., Haberlova, J., Hadzsiev, K., Hovhannesyan, K., Isohanni, P., Radovic, N. I., Jacquier, D., Jalloh, A., Jedrzejowska, M., Kandawasvika, G., Kaputu, C., Kawatu, N., Kernohan, K., Kirschner, J., Klink, B., Kodsy, S., Kouame-Assouan, A.-E., Kravljanac, R., Kreile, M., Litvinenko, I., McMillan, H., Mesa, S., Mohamed, I., Kanzoska, L. M., Nevo, Y., Nguefack, S., Nkole, K., O'Grady, G., O'Rourke, D., Oskoui, M., Piazzon, F., Poddighe, D., Prasauskiene, A., Prieto, J., Rasmussen, M., Razafindrasata, S., Saha, N., Saito, K., Sakadi, F., Sangare, M., Schroth, M., Shalkevich, L., Shatillo, A., Suthar, R., Szabo, L., Tatishvili, N., Tazir, M., Tizzano, E., Topaloglu, H., Tulinius, M., van der Pol, L., Vazquez, G., Vlodavets, D., Wanigasinghe, J., Wilmshurst, J., Xiong, H., Zafeiriou, D., & Zamba, E.
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 31
- Issue
- 6
- Pages
- 574-582
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W3143238609
- Cited by
- 176
- References
- 4
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.